8.JPG)
The Veterinary Injectable Devices Market Size is valued at USD 871.59 Million in 2023 and is predicted to reach USD 1406.96 Million by the year 2031 at a 6.5% CAGR during the forecast period for 2024-2031.
The market for veterinary injectable devices is predicted to expand significantly throughout the forecast period. The rising prevalence of numerous diseases among animals, as well as rising healthcare costs, are increasing the demand for veterinary injectable devices. Compared to companion animals, poultry and agricultural animals are at a higher risk of contracting sickness. If the disease spreads to farm animals or poultry, it can be fatal to all animals and humans. Farm animals and poultry mortality will result in financial losses. As a result, farm animals are vaccinated to prevent disease, resulting in increased sales of veterinary injectable devices. Syringes and needles are the top revenue-generating sectors of veterinary injectable devices and are likely to boost the market growth over the forecast period. The needle-free veterinary injectable systems market is growing and is likely to expand significantly over the next few years.
However, plastic is the preferred material for veterinary injectable devices as it's employed in the production of disposable injectable devices. Due to low prices and increased use of disposable injections, the plastic sector is projected to continue leading the veterinary injectable devices market.
The global veterinary injectable devices market is segmented based on devices, usage, and end-users. Based on devices, the market is segmented as syringes, needles, remote injection systems, and other device types. The other usage segment includes disposable, reusable, sterile, and other users (safety, etc.). By end-users, the market is categorized into animal research institutes & labs, veterinary hospitals, pet clinics, veterinary pharmacies, and other end-users.
The veterinary hospital's category is expected to hold a significant share in the veterinary injectable devices market in 2021. Advanced diagnostic imaging, innovative therapeutics, nuclear and regenerative medicines, laser diagnostics, and specialist operations, all of which are available in veterinary hospitals and clinics, are contributing to the growth. Market growth is expected to be aided by companies' strategic developments in the veterinary hospital segment. For instance, AAD recently announced a USD 7 million investment to extend its platform for rapid, point-of-care animal and human health choices. Moreover, the reference veterinary pharmacies sector is also predicted to grow at the fastest rate over the projection period, as these labs can test for a variety of illnesses, hazardous substances, and chronic disorders in animal specimens.
The syringes segment is projected to grow at a rapid rate in the global veterinary injectable devices market, owing to the high availability of syringes in the market. Market players' initiatives in this segment are also expected to boost market growth. As a result of technological advancements, Veterinary Syringes are now simple to use. In addition, they take less effort from animal keepers and deliver accurate and prompt findings.
North America is the most attractive and highest revenue-generating veterinary injectable devices market owing to better veterinary healthcare facilities and increased expenditure on companion animals. North America is one of the world's largest meat-consuming markets, with tight regulations requiring that meat come from healthy animals. Moreover, market growth is likely to be aided by the increased acceptance of pet health insurance in the United States. On the other hand, Asia Pacific is projected to proliferate in the global veterinary injectable devices market owing to rising animal healthcare infrastructure and the presence of many farm animals and big poultry businesses. Furthermore, market expansion in this region has been aided by factors such as increased adoption of companion animals and rising animal health concerns. In addition, the Asia Pacific region's market is predicted to be driven by increasing expenditure on animal health and veterinary services, as well as the growing cattle population.
|
Report Attribute |
Specifications |
|
Market size value in 2023 |
USD 871.59 Million |
|
Revenue forecast in 2031 |
USD 1406.96 Million |
|
Growth rate CAGR |
CAGR of 6.5 % from 2024 to 2031 |
|
Quantitative units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments covered |
By Devices, By Usage, By End-User |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Boehringer Ingelheim, TeleDart USA, H. Hauptner Und Richard Herberholz GmbH & Co. KG, Schippers Export BV, Akra Dermojet, Allflex Livestock Intelligence (SCR Engineers Ltd.), Terumo Medical Corporation, Neogen Corporation, Quick Shot Corporation, Syrinjector Ltd, Accesia, Aesthetic Group, AVID Pet MicroChip, Genia, Millpledge Veterinary, Nordson Efd, Pharma Supply Inc, UID Identification Solutions, Ultimed, and Vygon Vet. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Veterinary Injectable Devices Market Snapshot
Chapter 4. Global Veterinary Injectable Devices Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Industry Analysis – Porter’s Five Forces Analysis
4.6. Competitive Landscape & Market Share Analysis
4.7. COVID 19 Impact Analysis
Chapter 5. Market Segmentation 1: By Devices Estimates & Trend Analysis
5.1. By Devices & Market Share, 2019 & 2031
5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Devices:
5.2.1. Syringes
5.2.2. Needles
5.2.3. Remote Injection Systems
5.2.4. Other Device Type
Chapter 6. Veterinary Injectable Devices Market Segmentation 2: By Usage Estimates & Trend Analysis
6.1. By Usage Analysis & Market Share, 2019 & 2031
6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Usage:
6.2.1. Disposable
6.2.2. Reusable
6.2.3. Sterile
6.2.4. Other Usage (Safety, Etc.)
Chapter 7. Veterinary Injectable Devices Market Segmentation 3: By End-Users Estimates & Trend Analysis
7.1. By End-Users Analysis & Market Share, 2019 & 2031
7.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End-Users:
7.2.1. Animal Research Institutes & Labs
7.2.2. Veterinary Hospitals
7.2.3. Pet Clinics
7.2.4. Veterinary Pharmacies
7.2.5. Other End-Users
Chapter 8. Veterinary Injectable Devices Market Segmentation 3: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Veterinary Injectable Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Devices, 2024-2031
8.1.2. North America Veterinary Injectable Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Usage, 2024-2031
8.1.3. North America Veterinary Injectable Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By End-Users, 2024-2031
8.1.4. North America Veterinary Injectable Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2024-2031
8.1.4.1. U.S.
8.1.4.2. Canada
8.2. Europe
8.2.1. Europe Veterinary Injectable Devices Market revenue (US$ Million) and volume (No. of Units) By Devices, 2024-2031
8.2.2. Europe Veterinary Injectable Devices Market revenue (US$ Million) and volume (No. of Units) By Usage, 2024-2031
8.2.3. Europe Veterinary Injectable Devices Market revenue (US$ Million) and volume (No. of Units) By End-Users, 2024-2031
8.2.4. Europe Veterinary Injectable Devices Market revenue (US$ Million) and volume (No. of Units) by country, 2024-2031
8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific Veterinary Injectable Devices Market revenue (US$ Million) and volume (No. of Units) By Devices, 2024-2031
8.3.2. Asia Pacific Veterinary Injectable Devices Market revenue (US$ Million) and volume (No. of Units) By Usage, 2024-2031
8.3.3. Asia Pacific Veterinary Injectable Devices Market revenue (US$ Million) and volume (No. of Units) By End-Users, 2024-2031
8.3.4. Asia Pacific Veterinary Injectable Devices Market revenue (US$ Million) and volume (No. of Units) by country, 2024-2031
8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America Veterinary Injectable Devices Market revenue (US$ Million) and volume (No. of Units) By Devices, (US$ Million) 2024-2031
8.4.2. Latin America Veterinary Injectable Devices Market revenue (US$ Million) and volume (No. of Units) By Usage, (US$ Million) 2024-2031
8.4.3. Latin America Veterinary Injectable Devices Market revenue (US$ Million) and volume (No. of Units) By End-Users, (US$ Million) 2024-2031
8.4.4. Latin America Veterinary Injectable Devices Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2024-2031
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America
8.5. MEA
8.5.1. MEA revenue Veterinary Injectable Devices Market revenue (US$ Million) and volume (No. of Units) By Devices, (US$ Million) 2024-2031
8.5.2. MEA revenue Veterinary Injectable Devices Market revenue (US$ Million) and volume (No. of Units) By Usage, (US$ Million) 2024-2031
8.5.3. MEA revenue Veterinary Injectable Devices Market revenue (US$ Million) and volume (No. of Units) By End-Users, (US$ Million) 2024-2031
8.5.4. MEA revenue Veterinary Injectable Devices Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2024-2031
8.5.4.1. South Africa
8.5.4.2. Rest of MEA
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Boehringer Ingelheim
9.2.2. Henke-Sass, Wolf GmbH
9.2.3. TeleDart USA
9.2.4. H.Hauptner Und Richard Herberholz GmbH & Co. KG
9.2.5. Schippers Export BV
9.2.6. Akra Dermojet
9.2.7. Allflex Livestock Intelligence (SCR Engineers Ltd.)
9.2.8. Terumo Medical Corporation
9.2.9. Neogen Corporation
9.2.10. Quick Shot Corporation
9.2.11. Syrinjector Ltd
9.2.12. Accesia
9.2.13. Aesthetic Group
9.2.14. AVID Pet MicroChip
9.2.15. Génia
9.2.16. Millpledge Veterinary
9.2.17. Nordson Efd
9.2.18. Pharma Supply Inc
9.2.19. UID Identification Solutions
9.2.20. Ultimed
9.2.21. Vygon Vet
8.3. List of Other Prominent Players
By Devices -
By Usage -
By End-Users -
By Region -
North America -
Europe -
Asia-Pacific -
Latin America -
Middle East & Africa -
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
